Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Making new beta cells from stem cells.

Alan Colman1

  • 1ES Cell International, Singapore Science Park II, 41 Science Park Road #04-14/15, The Gemini 117610, Singapore. acolman@escellinternational.com

Seminars in Cell & Developmental Biology
|May 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ian Wilmut (1944-2023).

Science (New York, N.Y.)·2023
Same author

Isogenic Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes Reveal Activation of Wnt Signaling Pathways Underlying Intrinsic Cardiac Abnormalities in Rett Syndrome.

International journal of molecular sciences·2022
Same author

Directed differentiation of periocular mesenchyme from human embryonic stem cells.

Differentiation; research in biological diversity·2017
Same author

Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor.

Circulation·2016
Same author

Chondrocytes Derived From Mesenchymal Stromal Cells and Induced Pluripotent Cells of Patients With Familial Osteochondritis Dissecans Exhibit an Endoplasmic Reticulum Stress Response and Defective Matrix Assembly.

Stem cells translational medicine·2016
Same author

Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells.

Scientific reports·2016
Same journal

Editorial for special issue "When should mathematical models be used in biology".

Seminars in cell & developmental biology·2026
Same journal

Conserved machinery, divergent functions: evolutionary plasticity of the STK36/ULK4 kinase complex in ciliogenesis and signaling.

Seminars in cell & developmental biology·2026
Same journal

Chemical biology tools for studying tissue development.

Seminars in cell & developmental biology·2026
Same journal

Tetrahymena as a model organism for cilia research.

Seminars in cell & developmental biology·2026
Same journal

Emerging Concepts in Cardiovascular Development and Regeneration.

Seminars in cell & developmental biology·2026
Same journal

Endothelial origin of hematopoietic stem cells: Insights from new technologies and unresolved questions.

Seminars in cell & developmental biology·2026
See all related articles

Researchers are exploring alternative cell sources for Type 1 diabetes treatment. Adult stem cells show promise for generating insulin-producing cells, offering a potential alternative to cadaveric islets.

Area of Science:

  • Regenerative Medicine
  • Endocrinology
  • Stem Cell Biology

Background:

  • Human islet transplantation can restore insulin independence in Type 1 diabetes.
  • Limited availability of cadaveric islets necessitates alternative cell sources for therapy.
  • Embryonic stem cells (ESCs) and adult stem cells are investigated as potential islet surrogates.

Purpose of the Study:

  • To review progress in developing surrogate islet cells for Type 1 diabetes therapy.
  • To critically evaluate the potential and challenges of ESCs and adult stem cells for islet replacement.
  • To assess the methodologies for evaluating in vivo function of transplanted surrogate cells.

Main Methods:

  • Review of published literature on stem cell differentiation into insulin-producing cells.

Related Experiment Videos

  • Analysis of studies using embryonic stem cells and adult stem cells (ductal, liver).
  • Evaluation of in vivo models for assessing surrogate cell function in diabetic mice.

    • Main Results:

    • ESC-derived cells require careful interpretation due to potential insulin adsorption artifacts from growth media.
    • Adult stem cell research shows significant progress in generating insulin-secreting cells with potentially fewer artifacts.
    • In vivo assessment in diabetic mouse models often lacks optimal utilization, with ambiguity in attributing hyperglycemia reduction to transplanted cells versus endogenous recovery.

    Conclusions:

    • Adult stem cells may offer a more reliable source for insulin-producing cells compared to ESCs due to reduced artifact potential.
    • Improved methodologies are needed for robust in vivo assessment of surrogate islet cell function.
    • Further research is required to validate the efficacy and safety of stem cell-derived therapies for Type 1 diabetes.